Revenue: As of FY2026 Q1, the actual value is USD 11.71 M, beating the estimate of USD 9.826 M.

EPS: As of FY2026 Q1, the actual value is USD -0.71, missing the estimate of USD -0.69.

EBIT: As of FY2026 Q1, the actual value is USD -31.4 M.

Senseonics Holdings, Inc. issued a press release on May 7, 2026, announcing its financial results for the quarter ended March 31, 2026, and providing corporate highlights and outlook.

Revenue

Senseonics Holdings, Inc. generated total revenue of $11.7 million in Q1 2026, an 87% increase year-over-year compared to $6.3 million in Q1 2025. U.S. revenue for Q1 2026 was $9.3 million, an increase from $4.5 million in Q1 2025. Revenue outside the U.S. was $2.4 million in Q1 2026, compared to $1.8 million in the prior year period.

Gross Profit and Margin

Gross profit for Q1 2026 was $6.9 million, significantly up from $1.5 million in Q1 2025. The company achieved a gross margin of 59% in Q1 2026, representing a 35% increase year-over-year. Q1 2026 gross profit included a one-time benefit of $0.5 million related to the timing of the Eversense 365 product launch in Europe.

Operating Expenses

Research and Development (R&D) expenses increased by $1.3 million year-over-year to $8.6 million in Q1 2026 from $7.3 million in Q1 2025. Selling, General and Administrative (SG&A) expenses increased by $22.5 million year-over-year to $30.2 million in Q1 2026 from $7.7 million in Q1 2025. Operating loss was - $31.846 million in Q1 2026 compared to - $13.488 million in Q1 2025.

Net Loss

Senseonics Holdings, Inc. reported a net loss of - $32.3 million in Q1 2026, compared to a net loss of - $14.3 million in Q1 2025. Basic net loss per common share was - $0.71 in Q1 2026, compared to - $0.40 in Q1 2025. Diluted net loss per common share was - $0.71 in Q1 2026, compared to - $0.40 in Q1 2025.

Other Financials

Interest income was $742 thousand in Q1 2026, compared to $675 thousand in Q1 2025. Interest expense was - $1.192 million in Q1 2026, compared to - $1.429 million in Q1 2025. Other expense was - $37 thousand in Q1 2026, compared to - $17 thousand in Q1 2025. Total other income (expense), net was - $487 thousand in Q1 2026, compared to - $771 thousand in Q1 2025. Total comprehensive loss was - $32.394 million in Q1 2026, compared to - $14.262 million in Q1 2025.

Balance Sheet Highlights (as of March 31, 2026)

Cash, cash equivalents and investments totaled $64.6 million. Outstanding indebtedness was $35.2 million. Cash and cash equivalents were $29.612 million. Short term investments, net were $34.709 million. Total assets were $102.857 million. Total liabilities were $68.522 million. Total stockholders’ equity was $34.335 million.

Operational Metrics

Direct-to-consumer (DTC) new patient adds were up nearly 100% year-over-year. Senseonics Holdings, Inc. raised $92 million in growth capital through a recent public offering of securities and over $100 million in total equity and debt financing.

Outlook / Guidance

Senseonics Holdings, Inc. now expects full-year 2026 global net revenue to be approximately $60 – $64 million, an increase from the previously projected range of $58M to $62M. This represents year-over-year growth of 70% – 82%. Gross margins are anticipated to be approximately 55% – 58% for the full year.